(Q36209885)

12 August 2017

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk (English)

1 reference

12 August 2017

3

Armin Finkenstedt

1 reference

12 August 2017

Benedikt Schaefer

1

1 reference

12 August 2017

Philipp Würtinger

2

1 reference

12 August 2017

Vickie Braithwaite

4

1 reference

12 August 2017

André Viveiros

5

1 reference

12 August 2017

Maria Effenberger

6

1 reference

12 August 2017

Irene Sulzbacher

7

1 reference

12 August 2017

Alexander Moschen

8

1 reference

12 August 2017

Andrea Griesmacher

9

1 reference

12 August 2017

Herbert Tilg

10

1 reference

12 August 2017

Wolfgang Vogel

11

1 reference

12 August 2017

Heinz Zoller

12

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 December 2016

1 reference

12 August 2017

1 reference

12 August 2017

11

1 reference

12 August 2017

12

1 reference

12 August 2017

e0167146

1 reference

Creative Commons Attribution 4.0 International

12 August 2017

start time

1 December 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Potentially life-threatening phosphate diabetes induced by ferric carboxymaltose injection: a case report and review of the literature

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Ferric carboxymaltose: a review of its use in iron deficiency

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Clinical and histological spectrum of osteomalacia among Asians in south London.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

UK guidelines on the management of iron deficiency in pregnancy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5131956

Severe hypophosphataemia after intravenous iron administration

22 September 2018

1 reference

12 December 2020

Symptomatic hypophosphataemic osteomalacia secondary to the treatment with iron carboxymaltose detected in bone scintigraphy

1 reference

12 December 2020

[Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron]

1 reference

12 December 2020

Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient

1 reference

12 December 2020

Uncommon adverse effect of a common medication

1 reference

12 December 2020

Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0167146

Identifiers

DOI

1 reference

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

27907058

1 reference